Freenome

company

Number of Lead Investors

Number of Investors

Freenome is funded by 50 investors. Roche and Perceptive Advisors are the most recent investors.

Investor Name	Lead Investor	Funding Round
Roche	Yes	Corporate Round
Perceptive Advisors	Yes	Series D
RA Capital Management	Yes	Series D
Loxbridge Research	Yes	Seed
Andreessen Horowitz	-	Series D
ArrowMark Partners	-	Series D
Artis Ventures (AV)	-	Series D
Bain Capital Life Sciences	-	Series D
BrightEdge Fund	-	Series D
Byers Capital	-	Series D
Catalio Capital Management	-	Series D
Cormorant Capital	-	Series D
DCVC	-	Series D
Eventide	-	Series D
Farallon Capital Management	-	Series D
Fidelity Management and Research Company	-	Series D
GV	-	Series D
HBM Healthcare Investments AG	-	Series D
Intermountain Ventures	-	Series D
Janus Henderson Investors	-	Series D
Kaiser Permanente	-	Series D
Logos Capital	-	Series D
Novartis	-	Series D
Polaris Partners	-	Series D
Pura Vida Investments	-	Series D
Ridgeback Capital	-	Series D
Roche Venture Fund	-	Series D
Rock Springs Capital	-	Series D
Sands Capital Ventures	-	Series D
Section 32	-	Series D
Soleus Capital	-	Series D
Suvretta Capital Management	-	Series D
T. Rowe Price	-	Series D
Cormorant Asset Management	-	Series C
EcoR1 Capital	-	Series C
Kaiser Permanente Ventures	-	Series C
dRx Capital	-	Series B
Longevity Vision Fund	-	Series B
Verily	-	Series B
Anne Wojcicki	-	Series A
Asset Management Ventures (AMV)	-	Series A
CRV	-	Series A
Founders Fund	-	Series A
Innovation Endeavors	-	Series A
S28 Capital	-	Series A
Agent Capital	-	Series A
Allen & Company	-	Series A
AME Cloud Ventures	-	Series A
Charles River Associates	-	Series A
Third Kind Venture Capital	-	Seed